2025-07-29 Drugs SFDA Approves the Registration of “Leqembi” as the First Alzheimer’s Treatment in Saudi Arabia
2025-07-28 Medical Devices SFDA Strengthens Global Standing Through Regulation of Medical Device Clinical Studies
2025-07-23 Drugs SFDA Announces Registration of “Skyclarys” for the Treatment of a Rare Genetic Neurological Disorder
2025-07-20 Medical Devices SFDA Advances Healthcare Innovation Through Clinical Trials and Gene Therapy
2025-07-16 Drugs SFDA Approves Marketing Authorization for Diagnostic Medical Devices to Measure Antipsychotic Drug Levels in Blood
2025-07-14 Drugs SFDA Suspends European Pharmaceutical Factory Due to Critical Manufacturing Violations
